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Abstract 
Objective: The aim of this study was to investigate whether vascular diseases and 
diabetes influence cognitive impairment in cognitively healthy subjects. Moreover, we 
want to investigate whether vascular diseases have an additive effect on cognitive 
impairment in subjects diagnosed with MCI or dementia. 
 Methods: This study included 211 participants. We have separated the participants in 
2 mental status groups based on a research diagnosis by a specialist: cognitively 
healthy participants (patients with no cognitive problems of the clinical group + 
healthy participants of the control group; n = 93) and MCI/dementia patients (patients 
diagnosed with MCI or dementia; n= 118). Both groups were administered the 
Rowland Universal Dementia Assessment Scale (RUDAS) for measurement of 
cognitive decline. Differences in RUDAS scores were compared for participants with 
one or more vascular diseases and/or diabetes.  
Results: In the cognitively healthy population, we found significant effect of vascular 
risk factors on the RUDAS scores. Especially participants suffering from hypertension 
and diabetes at the same time had lower scores on the RUDAS.  
In the MCI/dementia population, we didn’t find an additive effect of vascular/diabetic 
risk factors on the RUDAS scores. 
Conclusion: Comorbidity of diabetes and hypertension further increases the risk of 
cognitive decline. This underlines the importance of prevention and treatment of 
diabetes and hypertension. In groups already diagnosed with MCI or dementia, the 
additive effect of carrying vascular risk factors or diabetes is absent. 
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Introduction  
Dementia is a general term for cognitive decline which interferes with social and 
occupational functioning. It constitutes one of the largest burdens for individuals and 
society (Story, Rowland, Conforti & Dickson, 2003). This disease affects around 7% 
of the general population older than 65 years, and 30% of people older than 80 years 
(O’Brien et al., 2003). A wide variety of cognitive symptoms occur in dementia, but 
memory loss is the most common feature of the disease. The two most common 
dementias are Alzheimer’s disease (AD), approximately 60% of all causes and 
vascular dementia (VaD), approximately 20 % of all causes (Skoog, 2009). Mild 
Cognitive Impairment (MCI) is a term referring to persons who do not fulfill the 
criteria of dementia and is often assumed to be the pre-dementia stage of AD and VaD 
(Rasquin et al., 2005).  
 Mild Cognitive Impairment is defined as cognitive impairment greater than 
expected for an individual’s age and intellectual status. In contrast to AD and VaD, 
patients diagnosed with MCI do not experience restrictions in daily life activities.  
Beside cognitive impairment, patients sometimes also experience behavioral and 
psychological problems such as depression and anxiety. These additional symptoms 
may predict the progression to clinical dementia (Gauthier et al., 2006). 
AD is characterized by cognitive impairment as well as personality and behavior 
problems. This syndrome is characterized by impairments of various aspects relative to 
premorbid levels. According to the National institute of Neurological and 
Communicative Disorders and Stroke and the Alzheimer’s Disease and Related 
Disorders Associations (NINDS-ADRDA) criteria, a diagnosis of AD involves memory 
impairment and at least one of the following symptoms: impairment of abstract 
thinking, aphasia, apraxia, agnosia, impairment in judgment or impairment in impulse 
control (McKhann et al., 2011). Some authors also believe that AD is a vascular 
disorder (Wiederkehr et al., 2008).   
Vascular Dementia remains a diagnostic challenge in clinical settings, because 
it relates to different vascular mechanisms and has different manifestations. VaD 
requisites vascular etiologies such as cerebrovascular diseases, vascular risk 
factors, brain infarcts, white matter lesions, and atrophy. This disease is characterized 
by an abrupt onset and a stepwise deteriorating course.  The most common cognitive 
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symptoms are memory loss, slower speed of thought, visuospatial impairment and 
problems with executive functioning (Wiederkehr et al., 2008).   
Since the 1970s, the concept of VaD, dementia secondary to vascular disease, has been 
distinguished from the purely neurodegenerative form of AD. 
The exact mechanism by which vascular risk factors might increase the rate of 
cognitive decline in dementia is unclear and may have multiple explanations (Decarli, 
2004). However, Viswanathan, Rocca and Tzourio (2009) suggest that vascular and 
degenerative mechanisms actually develop in parallel. Cerebral ischemic or 
hemorrhagic lesions caused by vascular factors may induce the development of 
plaques and tangles associated with AD. It is also suggested that pure vascular 
dementia is uncommon at brain autopsy. Recent neuropathological findings showed 
that mixed Alzheimer’s disease/vascular dementia is more ordinary (Wiederkehr et 
al., 2008). Previous studies have shown that vascular risk factors affect not only heart 
and cerebrovascular diseases, but cognition as well (Luchsinger & Mayeux, 2004). 
Interest has increased over the past decade in the hypothesis that risk factors 
experienced in childhood, young adulthood, or middle age contribute to late-life 
dementia. Such a view emphasizes the importance of primary prevention (Haan, 
2010). Consequently, the relevance of vascular risk factors such as hypertension, 
diabetes mellitus, smoking and hypercholesterolemia should be studied for the 
spectrum of all dementias.  
   It has been suggested that hypertension is associated with a wide variety of 
cognitive impairment, including reduced abstract reasoning (executive dysfunction), 
impaired memory, attention deficit, and slowing of mental processing speed (Iadecola, 
2014). Increasing evidence suggests that hypertension is a risk factor for AD. 
Hypertension has major effects on the regulation of the cerebrovascular circulation, 
which may impair the  brain structure and function by reducing vascular reserves and 
promoting ischemic injury (Iadecola, 2014). Hypertension has also been associated 
with atrophy of the left frontal lobe, which may cause alterations in executive 
functioning (Iadecola, 2014). Moreover, some research has shown an association 
between hypertension and the presence of senile plaques and neurofibrillary tangles, 
the hallmarks of AD in the brain (Skoog, 2009).   
 Diabetes Mellitus might also be related to cognitive impairment (McGrimmon, 
Ryan & Frier, 2012). One obvious explanation would be that it is not the diabetes per 
se but the vascular involvement of diabetes that results in neurodegeneration. Another 
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explanation is that neuronal insulin receptor resistance and subsequent cerebral 
glucose metabolism abnormalities associated with diabetes could lead to cognitive 
deficits (Lovestone, 1999). However, a recent study has not found a association 
between diabetes mellitus and the performance on cognitive questionnaires (Nielsen, 
Vogel, Gade & Waldemar, 2012). On the other hand, previous studies show that 
comorbidity of diabetes and hypertension produce a pronounced cognitive decline 
(Hassing et al., 2004).  
Another study reports that high blood cholesterol levels may also be associated 
with cognitive impairment and that it might be a typical characteristic of late-onset 
dementia (Zulani et al., 2010). Previous studies have shown an association between 
vascular diseases and cognition. It is essential to focus on factors which are 
modifiable. Vascular risk factors are all possibly modifiable factors (Luchsinger & 
Mayeux, 2004). For example, high blood pressure can be treated with medication, and 
people can be encouraged to quit smoking. This knowledge will provide an 
opportunity to detect and modify vascular risk factors in the elderly to prevent 
cognitive decline in later stages of life. 
It is important to objectively test cognition in individuals at risk for, or suspected 
of, cognitive decline. Cognitive deficits relate more clearly to the progression of 
dementia than other related factors such as mood changes (Story, Rowland, Conforti & 
Dickson, 2003). Consequently, it is also important to determine the stages of dementia.  
Cognitive scales such as the Mini-mental State Examination (MMSE) are widely used. 
The MMSE has important disadvantages in elderly migrant populations because the 
score is influenced by education and illiteracy. The Rowland Universal Dementia 
Assessment Scale (RUDAS) was specifically designed for an elderly migrant 
population in Australia and proved useful in culturally diverse populations in different 
countries (Naqvi et al., 2015). The RUDAS tests multiple cognitive domains and 
therefore it seems to be a more comprehensive assessment of a subjects overall 
cognitive ability than the MMSE (Story, Rowland, Conforti & Dickson, 2003).  
 The purpose of this research is to find out whether carrying vascular diseases 
contributes to cognitive impairment in a group of elderly migrants, of predominantly 
Turkish and Moroccan descent. Previous research showed that the number of vascular 
risk factors partly predicted the degree of cognitive impairment in healthy elderly on 
the Cross-Culturele Dementiescreening (CCD) (Onur, 2016). Our objective is to find 
out whether lower scores in elderly migrants with vascular diseases and/or diabetes 
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mellitus can also be detected with the RUDAS. We will investigate this in two 
subgroups: cognitively healthy subjects and cognitively impaired/demented subjects. 
We will compare subjects of the clinical group diagnosed with dementia, but without 
vascular disease with subjects of the clinical group diagnosed with dementia plus 
vascular diseases to find out the additive effect of vascular diseases on cognitive 
impairment. Besides we compare subjects of the healthy group with and without 
vascular diseases.  
Vascular diseases are defined as: hypertensia, CVA, Aneurysma, Angina 
Pectoris, Myocard infarction, Decompensatio Cordis and Claudicatio Intermittens. 
Subjects carrying vascular diseases are hypothesized to have lower scores on the 
RUDAS as compared to subjects without vascular diseases.  
Further, we will analyze the relationship between RUDAS scores of subjects carrying 
diabetes mellitus with subjects without diabetes mellitus. We expect that subjects 
carrying diabetes mellitus may have lower scores compared to subjects without diabetes 
mellitus. 
We have to take into account that more factors can have an effect on the cognition, for 
example age and education level. When necessary, these factors will be statistically 
corrected for. 
In Summary, the research questions of this study are: 1. Are vascular diseases and 
diabetes related to cognitive impairments in cognitively healthy and cognitively 
impaired subjects? 
2. Do vascular diseases have an additive effect on cognitive impairment in subjects 
diagnosed with MCI or dementia?  
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Methods  
 
Design  
 A control group and a clinical group are embedded in this observational cross-sectional 
research design. The design is approved by the Medical Ethical Testing Committee 
(METC) of MC Slotervaart. 
 
Participants  
The cognitively healthy participants (control group) were recruited by two master 
students. This sample consisted of 50 participants with a minimum age of 55 years, of 
Turkish and Moroccan descent. The participants of the control group were recruited 
through the snowball method (acquaintances) and community centers and mosques. 
Participants with cognitive disorders or a history of psychiatric illnesses were excluded. 
  The participants of the clinical group were recruited in MC Slotervaart in 
Amsterdam and Erasmus MC and Havenziekenhuis in Rotterdam. This sample 
consisted of 161 non-Western migrant participants who were referred to the memory 
clinic with a minimum age of 55 years. These participants were diagnosed with 
dementia, Mild Cognitive impairment or no cognitive decline. Criteria for exclusion 
were being untestable and refusing to participate.   
We have separated the participants in 2 mental status groups: cognitively healthy 
participants (patients with no cognitive problems of the clinical group + cognitively 
healthy participants of the control group) and MCI/dementia patients (patients 
diagnosed with MCI or dementia). Figure 1 gives a detailed overview of the research 
process. 
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Figure 1. research process 
 
Procedure 
The cognitively healthy participants (N = 50) were approached in community centers 
and mosques. During this meeting they were invited to participate in the study. The 
researchers read an outline of the study objectives and the practical implications for the 
participants. All participants signed an informed consent form prior to participation. 
The duration of the appointment was ca. 30 minutes. All involved in the study were 
granted the right to withdraw at any time. After this confirmation the participants were 
asked about their health condition to investigate whether vascular diseases and/ or 
diabetes were present or not. Afterward the Mini-mental State Examination (MMSE) 
and The Rowland Universal Dementia Assessment Scale (RUDAS) were administered. 
In addition, we asked the family members of the participants to fill in the IQCODE 
questionnaire. Subsequently the participants received a small financial compensation 
for their participation.  
 The participants of the clinical group were administered the Mini-Mental State 
Examination (MMSE) and The Rowland Universal Dementia Assessment Scale 
(RUDAS) at the memory clinic of MC Slotervaart in Amsterdam. These questionnaires 
were administered by trained nurses. Besides, other cognitive tests were administered 
(CCD, Seven Minute Screen).  The participants were asked about their health condition 
as part of a clinical interview conducted by trained geriatrician.  In addition, The 
Clinical Dementia Rating (CDR) was filled in to quantify the degree of cognitive 
Clinical group 
N = 161 
Dementia 
 N = 72 
 
MCI 
 N = 46 
 
Cognitively 
healthy 
 N = 43 
 
Community 
control 
N = 50 
MCI/Dementia 
participants 
N = 118 
Cognitively healthy 
participants 
N = 93 
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impairment. All participants of the clinical group were given a clinical diagnosis of 
dementia (subtyping according to existing guidelines), MCI, other or no cognitive 
disturbances by a geriatrician, based on all clinical information except scores on the 
MMSE, RUDAS and IQCODE to avoid confirmation bias. 
 
Measures  
Cognitive impairment was measured using the RUDAS (Story, Rowland, Conforti & 
Dickson, 2003). The RUDAS contains 6-items which assess multiple cognitive 
domains including memory, praxis, language, judgment, drawing and body 
orientation. The maximum score is 30 points, with a higher score reflecting better 
performance, and an advised cut-off score of < 23. The MMSE was also administered 
(Kok & Verhey, 2002). The MMSE contains 15 questions about orientation, memory, 
praxis, language, drawing, writing and calculation.  The MMSE has a cut off score of 
24. A score lower than 24 was considered as a deviating score. The maximum score is 
30 points.  
The existence of vascular diseases was measured with the health condition 
questionnaire. This questionnaire contains some questions about education, cognitive 
disorders, psychiatric illnesses and cardiovascular diseases. The IQCODE 
questionnaire contains questions about cognitive decline to be answered by an 
informant (Jorm, 2004).  He or she is asked to rate the degree of cognitive decline in 
the past 10 years of the participant in different domains of daily living. A score of 3.8 
or higher indicates cognitive decline. A study indicates that the IQCODE has a 
sensitivity of 73% and specificity of 75% for diagnosis of dementia (Jorm, 2004). We 
used to short form consisting of 16 items (IQCODE-sf) with scores ranging from 0 
(cognitive improvement compared with 10 years ago to 5 (clear cognitive decline 
compared with 10 years ago). The IQCODE-SF has a sensitivity of 80 % to identify 
mild cognitive impairment and 90 % to identify adults at risk of dementia, including 
in the hospital (Jorm, 2004).   
The Clinical Dementia Rating (CDR) was administered by the doctors for participants 
of the clinical group to determine the degree of the cognitive impairment. The CDR is 
used to characterize six domains of cognitive and functional performance: Memory, 
Orientation, Judgment & Problem Solving, Community Affairs, Home & Hobbies and 
Personal Care (Berg, 1988).  
10 
 
The CDR domain scores and the total global CDR score are both rated on five levels: 
0 (no cognitive impairment), 0.5 (very mild dementia), 1 (mild dementia), 2 
(moderate dementia) or 3 (severe dementia). To determine the degree of cognitive 
impairment in this study we calculated the ‘sum of boxes score’ (CDR-SOB). We 
calculated the CDR-SOB by adding all scores on each of the six domains, resulting in 
a score ranging from 0 to 18.  
 
 
Statistical analyses  
All analyses are performed by IBM SPSS 24 with a confidence interval of 95 %. We 
expect that participants carrying vascular diseases scores lower on the RUDAS 
compared to participants without vascular diseases. Moreover, the presence of high 
blood pressure and diabetes at the same time could have a stronger effect on the 
cognition than either on alone. Patients diagnosed with MCI or dementia would have 
probably lower scores on the RUDAS as compared to healthy participants.  
The variable vascular factors consists of 4 categories, distinguished within each group 
(cognitively healthy and impaired). The categories are: high blood pressure, diabetes, 
the presence of high blood pressure and diabetes at the same time, and no vascular 
factors present. An analysis of covariance (ANCOVA) is used in this study within the 
healthy population to determine whether vascular factors have an effect on the 
cognition. Besides, we want to explore which specific vascular factor(s) has an 
influence on the cognition. Before starting the analyses, the assumptions for ANCOVA 
are checked. We assume that demographic factors could possibly have an impact on 
cognition as well. These factors will be taken into account by encoding them as 
covariates  
The Kruskal Wallis H test is used in this study whitin for the MCI/dementia population 
to determine whether vascular factors have an effect on the cognition.  
A post-hoc Mann Whitney U test is used to make an additional exploration of the 
pairwise differences among the means within the vascular factor categories.  
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Results 
 
Participants 
This research included 222 participants, however for the analyses we selected 211 
participants due to missing values. Missing values are the aftereffect of incomplete 
data due to lack of time or losing the test result of the participants.  
 
Demographic characteristics are described in table 1. The number of healthy 
participants was 93. The number of men and women were respectively 43 and 50. The 
age of the participants varied between 55 and 89 years. The mean age of the 
participants was 66.7 years (SD = 9.5). The nationality of the participants is diverse. 
The most common nationalities in this research are Turkish participants and 
Moroccan participants. There are also participants from China, Iraq and Iran. 
Most of the participants haven’t got education or have attended school less than 6 
years. 
 
The number of participants with cognitive problems is 118. The number of men and 
women were respectively 52 and 66. The age of the participants varied between 55 
and 95 years. The IQCODE-sf and CDR-SOB provides us more information about the 
degree of cognitive decline of the participants. Moreover, most of the participants 
haven’t got any education. Age and education are considered as covariates.  
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Table 1     
Demographic characteristics  Cognitively 
Healthy 
participants 
(N=93) 
MCI/Dementia 
participants  
(N=118) 
 
 
N % or mean  
(SD) 
%  or mean (SD) p 
Age  211 66.7 (9.5) 75 (8.0) 0.002 
Gender (%man) 211 46.2 44.1 0.552 
Education (Verhage)    0.015 
No education 211 34.4 53.4  
Finished primary school 211 35.5 21.2  
Did not finish secondary school 211 7.5 10.2  
Finished secondary school, low level 211 1.1 5.1  
Finished secondary school, medium 
level 
211 7.5 3.4  
Finished secondary school, highest 
level and/ or college degree 
211 9.7 2.5  
University degree 211 2.2 1.7  
IQCODE-sf 140 3.2 (0.3) 4.1 (0.5)  
CDR-SOB 128 1.4 (2.0) 6.0 (4.6)  
IQCODE-sf = The informant Questionnaire on Cognitive Decline in the Elderly-short form. 
CDR-SOB = The Clinical Dementia Rating-Sum of Boxes score. 
Note: Test of significance based on T-test (p < 0.05) and Pearson Chi-Square (p < 0.05).  
     
 
Diabetes Mellitus and Vascular characteristics  
From the figures it is apparent that 38 percent of the healthy participants have diabetes 
mellitus. Besides, 55 percent of the MCI/dementia participants have diabetes mellitus. 
Furthermore, 43 percent of the healthy participants have hypertension and 39 percent 
of the MCI/dementia participants have hypertension. Other vascular diseases such as 
TIA/ CVA, aneurysma, angina pectoris, myocardinfarct, decompensatio cordis, 
claudicatio intermittens are less common in this concerned population. Due to missing 
values the amount of participants included in the analyses was 209.  
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In both groups, the most common vascular diseases are diabetes and 
hypertension (high blood pressure). TIA, Myocardinfoarct en Claudicatio are more 
common in the MCI/dementia group than the Healthy group. We have divided the 
vascular / diabetic variable into four sets; absence of vascular diseases and diabetes, 
presence of hypertension, presence of diabetes mellitus, presence of both hypertension 
and diabetes mellitus. The occurrences of Diabetes Mellitus and Vascular factors are 
described in table 2. 
 
 
 
Table 2 
    
Diabetes Mellitus and Vascular 
characteristics 
 Cognitively healthy 
participants 
MCI/Dementia 
participants 
 
 N % (n)  % (n)  p 
Diabetes  209 37.6 55.1  0.070 
Hypertension 209 43.0 38.8 0.482 
TIA/CVA 209 9.7 19.5 <0.001 
Aneurysma 209 - -  
Angina Pectoris 209 5.4 7.6 0.171 
Myocardinfarct 209 5.4 12.7 <0.001 
Decompensatio Cordis 209 8.6 7.6 0.660 
Claudicatio Intermittens 209 2.2 5.9 0.005 
TIA/CVA= transient ischemic attack/cerebrovascular accident  
 
 
Table 4 gives an overview of the RUDAS scores in the different category groups of 
vascular factors, with and without MCI/dementia. 
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Table 4 
RUDAS scores (0-30) Cognitively healthy 
participants  
(N = 93) 
MCI/Dementia 
participants (N = 103) 
Diabetic / vascular factors Mean ± SD (N) Mean ± SD (N) 
 
Absence of hypertension 
and diabetes 
25.3 ± 2.6 (38) 18.0 ± 5.3 (26) 
Hypertension 24.2 ± 3.3 (15) 17.5 ± 5.4 (35) 
Diabetes Mellitus 25.3 ± 2.6 (20) 16.0 ± 6.6 (20) 
Presence of hypertension 
and diabetes Mellitus  
22.9 ± 2.9 (20) 18.7 ± 6.6 (22) 
Total 24.6 ± 2.9 (93) 17.7 ± 5.9 (103) 
   
 
The contribution of diabetic and vascular factors on the cognition 
 
We have conducted for both groups (healthy participants and MCI/dementia 
participants) a normality test. As can be seen from the Shapiro-Wilk test of normality, 
the RUDAS scores of the healthy population are not normally distributed (p = 0.01). 
However, the RUDAS scores in the MCI/dementia population are according to the 
Shapiro-Wilk test normally distributed (p = > 0.05).  
By analyzing the healthy population, we find significant effect of vascular factors on 
the RUDAS scores (X2 = 10.4, p = <0.05). By conducting a post-hoc Mann-Whitney 
test we find out that especially participants carrying hypertension and diabetes at the 
same time have lower scores on the RUDAS.  Table 5 gives a detailed overview. 
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Table 5. RUDAS scores in the cognitively healthy group for 4 groups of vascular 
disease  
RUDAS total 
score (0-30) 
    
 Diabetic / vascular factors N Mean Rank  p 
 Absence of hypertension and diabetes 
(Reference group) 
38 52,86  
 Hypertension 15 45,33 0.392 
 Diabetes Mellitus 20 53,38 0.954 
 Presence of hypertension and diabetes 
Mellitus 
20 30.75 0.003 
 Total 93  0.016 
Note: Test of significance based on Mann-Whitney U test.  
 
By analyzing the MCI/dementia population, we didn’t find an effect of 
vascular/diabetic factors on the RUDAS scores (F = 0.94, p = 0.628). Even by 
correcting for age and education we didn’t find any effect (F = 1.52, p = 0.188).  
 
Moreover, by conducting a mixed ANOVA for both the cognitively healthy 
population and the MCI/dementia population together, the results show that there is 
no interaction effect between vascular factors/diabetes and the group factor 
(MCI/dementia vs. Healthy) on the RUDAS scores (F = 1.67, p = 0.175). However, 
there is a significant main effect of group on the RUDAS scores (F= 97.26, p = < 
0.001). There is no significant effect of vascular factors on the RUDAS scores (F = 0. 
52, p = 0.669).  
Age has a significant effect on the RUDAS scores (F = 6.98, p = 0.010). Moreover, 
there isn’t a significant effect of education on the RUDAS scores (F = 0.10, p = 
0.919).   
 
 
 
 
 
 
16 
 
 
 
 
Discussion 
 
This study was performed to discover whether vascular factors and diabetes are related 
to cognitive impairments in cognitively healthy subjects and to discover whether 
vascular diseases have an additive effect on cognitive impairment in subjects diagnosed 
with dementia.   
This study shows that cognitively healthy participants of 55 years and older, 
have lower scores on a cognitive status instrument when they have hypertension 
together with diabetes. Despite the fact that they do not meet criteria for Mild Cognitive 
Impairment or dementia, they perform worse than elderly without those two risk factors. 
This effect has been found before by Hassing et al. (2004) and suggests that vascular 
factors plus diabetes form a risk for cognitive decline. Studies have shown that diabetes 
may results in neurodegeneration (Lovestone, 1999). Both hypertension and diabetes 
have underlying vascular mechanisms in which they interact (Hassing et al., 2004). An 
explanation of the comorbidity of diabetes and hypertension may be that multiple risk 
factors may increase the risk of cognitive decline. A recent study suggests that multiple 
vascular risk factors and diseases increase the amount of executive impairment 
(Villeneuve, 2009).   
Participants who only had vascular risk factors or only diabetes did not have lower 
RUDAS scores. A greater decline among the participants carrying vascular diseases 
would have been expected given the many findings showing this results (Iadecola, 
2014). These findings may possibly be a result of high age of our participants, as several 
investigations suggests that the negative effects associated with hypertension may vary 
with age such that greater effects are found among young participants as compared to 
older samples (Hassing et al., 2004). An explanation for the absence of the relationship 
between diabetes and cognitive decline may be the insensitivity of the RUDAS for 
cognitive impairment associated with diabetes. A previous study suggest that the 
RUDAS is not sensitive to cognitive impairment associated with diabetes,  
(Mccrimmon et al., 2012).  
In groups already diagnosed with MCI or dementia, the additive effect of carrying 
vascular risk factors or diabetes is absent. The most plausible explanation for this is that 
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when the degree of cognitive impairment has reached a certain threshold, the relative 
effect of vascular risk factors and diabetes is too small to detect.  
However, by analyzing the whole sample, healthy population and MCI/dementia 
population together, we found an effect of age on the RUDAS scores. This is 
understandable because cognition changes across the adult life span and may lead to 
cognitive impairment related to aging (Mather, 2010).  
However, we have to be cautious when interpreting our results, as there are some 
limitations in our study. A limitation of this study was the relatively young control 
group as compared to the clinical group. This is probably due to a recruitment bias 
(despite efforts to prevent this) as all of our participants of the clinical group where 
recruited from the hospital where the age of patients was relative older.  
Furthermore, the community volunteers were recruited by two master students. 
Vascular and diabetic factors were not clinically measured by physicians in these 
patients but obtained by self report, which might have resulted in over-or 
underreporting.  
Another limitation is the binary use of the vascular and diabetic factors 
(absence/presence) rather than using continuous scale (e.g. blood pressure level and 
diabetic blood sugar level). A continuous scale measure could provide us profoundly 
information.  
Strength of the study include that neuropsychologists in hospitals performed all 
assessments with the help of an interpreter, rather than a bilingual researcher by the 
clinical participants. Because a great part of the research population consists of etnic 
minority groups. 
In future studies it will be interesting to investigate wheter intervention of 
hypertension and diabetes improves the cogntive status of participants.  
  To summarize, this study demonstrates that comorbidity of diabetes and 
hypertension increases the risk of cognitive decline in cognitively healthy people. 
This underlines the importance of prevention and treatment of diabetes and 
hypertension. However, these factors do not have an additive effect in people who 
already are cognitively impaired.   
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